![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Lenacapavir as part of a Combination Regimen in Treatment-Naïve People with HIV: Week 54 Results
|
|
|
CROI 2022 Feb 16
Samir K. Gupta,1 James Sims,2 Cynthia Brinson,3 Frederick A. Cruickshank,4 Godson Oguchi,5
Javier Morales,6 Theo Hodge,7 Craig Dietz,8 Angela S. Liu,9 Laurie VanderVeen,9
Hadas Dvory-Sobol,9 Martin S. Rhee,9 Jared M. Baeten,9 Ellen Koenig10
1Indiana University School of Medicine, Indianapolis, IN, USA; 2St. Hope Foundation, Bellaire, TX, USA; 3Central Texas Clinical Research, Austin, TX, USA; 4Rosedale Infectious Diseases, Huntersville, NC, USA; 5Midland Florida Clinical Research Center, LLC, Deland, FL, USA; 6Clinical Research Puerto Rico Inc, San Juan, Puerto Rico, USA; 7Washington Health Institute, Washington DC, USA; 8Kansas City Care Health Center, Kansas City, MO, USA; 9Gilead Sciences Inc., Foster City, CA, USA; 10Instituto Dominicano de Estudios Virológicos, Santo Domingo, Dominican Republic
![0216221](../images/021622/021622-8/0216221.gif)
![0216222](../images/021622/021622-8/0216222.gif)
![0216223](../images/021622/021622-8/0216223.gif)
![0216224](../images/021622/021622-8/0216224.gif)
![0216225](../images/021622/021622-8/0216225.gif)
![0216226](../images/021622/021622-8/0216226.gif)
![0216227](../images/021622/021622-8/0216227.gif)
![0216228](../images/021622/021622-8/0216228.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|